Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 601 AL 615

Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson's Disease

Xie F, Gao X, Yang W, Chang Z, Yang X, Wei X, Huang Z, Xie H, Yue Z, Zhou F, Wang Q.

ACS Chem Neurosci. 2019 Feb 20;10(2):973-990. doi: 10.1021/acschemneuro.8b00520. Epub 2019 Jan 11.

Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration

Zhang S, Wang R, Wang G.

ACS Chem Neurosci. 2019 Feb 20;10(2):945-953. doi: 10.1021/acschemneuro.8b00454. Epub 2019 Jan 17.

[Plasmalogenes in the pathophysiology and therapy of age-specific diseases.]

Kytikova OY, Novgorodtseva TP, Antonyuk MV, Gvozdenko TA.

Adv Gerontol. 2019;32(6):948-958.

Rotenone: from modelling to implication in Parkinson's disease

Radad K, Al-Shraim M, Al-Emam A, Wang F, Kranner B, Rausch WD, Moldzio R.

Folia Neuropathol. 2019;57(4):317-326. doi: 10.5114/fn.2019.89857.

Development of the Integrated Parkinson's Care Network (IPCN): using co-design to plan collaborative care for people with Parkinson's disease

Kessler D, Hauteclocque J, Grimes D, Mestre T, Côtéd D, Liddy C.

Qual Life Res. 2019 May;28(5):1355-1364. doi: 10.1007/s11136-018-2092-0. Epub 2019 Jan 2.

Improvement of gait and balance by non-invasive brain stimulation: its use in rehabilitation

Ghosh S.

Expert Rev Neurother. 2019 Feb;19(2):133-144. doi: 10.1080/14737175.2019.1564042. Epub 2019 Jan 7.

Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas

Area-Gomez E, Guardia-Laguarta C, Schon EA, Przedborski S.

J Clin Invest. 2019 Jan 2;129(1):34-45. doi: 10.1172/JCI120848. Epub 2019 Jan 2.

Exosomes of pasteurized milk: potential pathogens of Western diseases

Melnik BC, Schmitz G.

J Transl Med. 2019 Jan 3;17(1):3. doi: 10.1186/s12967-018-1760-8.

Autonomic dysfunction in Parkinson disease and animal models

Metzger JM, Emborg ME.

Clin Auton Res. 2019 Aug;29(4):397-414. doi: 10.1007/s10286-018-00584-7. Epub 2019 Jan 2.

Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease

Liguori C, Mercuri NB, Albanese M, Olivola E, Stefani A, Pierantozzi M.

J Neurol. 2019 Mar;266(3):636-641. doi: 10.1007/s00415-018-09179-8. Epub 2019 Jan 3.

Is risperidone effective in reducing challenging behaviours in individuals with intellectual disabilities after 1 year or longer use? A placebo-controlled, randomised, double-blind discontinuation study

Ramerman L, de Kuijper G, Scheers T, Vink M, Vrijmoeth P, Hoekstra PJ.

J Intellect Disabil Res. 2019 May;63(5):418-428. doi: 10.1111/jir.12584. Epub 2019 Jan 4.

Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology

Longhena F, Faustini G, Spillantini MG, Bellucci A.

Int J Mol Sci. 2019 Jan 2;20(1):141. doi: 10.3390/ijms20010141.

Roco Proteins: GTPases with a Baroque Structure and Mechanism

Wauters L, Versées W, Kortholt A.

Int J Mol Sci. 2019 Jan 3;20(1):147. doi: 10.3390/ijms20010147.

Glutamine protects against oxidative stress injury through inhibiting the activation of PI3K/Akt signaling pathway in parkinsonian cell model

Zhao Y, Wang Q, Wang Y, Li J, Lu G, Liu Z.

Environ Health Prev Med. 2019 Jan 5;24(1):4. doi: 10.1186/s12199-018-0757-5.

Applications of nanotechnology in drug delivery to the central nervous system

Saeedi M, Eslamifar M, Khezri K, Dizaj SM.

Biomed Pharmacother. 2019 Mar;111:666-675. doi: 10.1016/j.biopha.2018.12.133. Epub 2019 Jan 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias